Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIPB for ITA Harvesting in CABG
NCT07663435Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine in pain (2 arms), sponsored by Ain Shams University. Primary endpoints: Change in Internal Thoracic Artery (ITA) Diameter at 15 minutes and Change in Internal Thoracic Artery (ITA) Cross-Sectional Area at 15 minutes. Started Jul 2026; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07663435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07663435.